Introduction
The influence of vitamin D in bone metabolism is well established, and vitamin D is hypothesized by some to influence other chronic diseases as well (1) 
. Blood concentrations of 25-hydroxyvitamin D [25(OH)D]
7 above the range of 30 to 50 nmol/L are reported to be associated with optimal bone health (1) . Therefore, a better understanding of predictors of change in 25(OH)D is needed to determine which modifiable and nonmodifiable factors may influence oneÕs status over time (i.e., years).
A number of cross-sectional studies have shown that factors such as vitamin D intake (both from diet and supplements), season of blood draw, sunlight exposure, age, race, adiposity, and physical activity predict 25(OH)D measured at one time point (2) (3) (4) (5) (6) (7) (8) (9) . However, few studies have prospectively examined predictors of change in 25(OH)D concentrations. Intraindividual variation in 25(OH)D over time has been shown by some to be moderate (10) (11) (12) (13) (14) , and data suggest that 25(OH)D concentrations do in fact change over time (13) (14) (15) (16) . Obtaining a better understanding of the predictors of change in 25(OH)D might clarify how these and other factors contribute to the maintenance or achievement of vitamin D adequacy ($50 nmol/L), as defined by the Institute of Medicine (17) . In the few studies that prospectively examined predictors of change in 25(OH)D, predictors included measures of body size (13, 15) , physical activity (13) , vitamin D intake (13) , and exogenous estrogen dose (18) . Only 2 of these studies examined change over a period of years (13, 15) .
Using data from the Osteoporosis and Periodontal Disease (OsteoPerio) Study, an ancillary study of the WomenÕs Health Initiative Observational Cohort Study (WHIOS) conducted in Buffalo, NY, we prospectively examined the predictors of 5-y change in plasma 25(OH)D in a sample of 668 postmenopausal women. This study contains extensive information on key variables for studying predictors of change in 25(OH)D and includes data on demographic characteristics, dietary and supplement intake, body composition, other lifestyle factors, and medication use. We hypothesized that change in 25(OH)D would be predicted by baseline measures of 25(OH)D and baseline and change measures of vitamin D intake from food and supplements; measures of sunlight exposure, body size, and bone mineral density; and other health and lifestyle factors that could affect vitamin D status.
Participants and Methods

Study sample
The WHIOS is a prospective cohort study that investigates the major causes of morbidity and mortality in 93,676 postmenopausal women (ages 50-79 y at enrollment) recruited from 40 clinical sites across the United States (1993) (1994) (1995) (1996) (1997) (1998) (19) (20) (21) . The OsteoPerio Study is an ancillary study of the WHIOS that investigated the association between osteoporosis and periodontal disease in postmenopausal women. Women enrolled in WHIOS at the Buffalo, NY, clinic center (n = 2249) were invited to participate in the OsteoPerio Study (1997-2000) (22) . Of these, 338 were deemed ineligible [had <6 teeth (n = 162), history of bone disease (n = 2), both hips replaced (n = 16), cancer diagnosed in the past 10 y (n = 106), or other serious illnesses (n = 52)] and 549 were uninterested, lost to follow-up or died, leaving 1362 eligible women who completed the OsteoPerio Study baseline assessment. Of these, 934 women had sufficient baseline plasma samples for determination of 25(OH)D as well as complete baseline questionnaires and available data on periodontal disease [insufficient plasma samples (n = 407), missing baseline questionnaire data (n = 5), missing oral radiographs (n = 16); as previously described (14)]. Of these women, 673 also had sufficient plasma at OsteoPerio Study follow-up [details of follow-up exam previously described (23) ]. Women were further excluded if they had colitis (a malabsorptive condition that could affect vitamin D absorption; n = 3). Two additional participants were excluded due to outlying 25(OH)D concentrations (530 nmol/L at baseline and 186 nmol/L at follow-up). The final sample used in analyses was composed of 668 women (see Supplemental Fig. 1 for the OsteoPerio Study participant flow diagram). The study was approved by the institutional review board at the University at Buffalo, and women provided written informed consent to participate in the WHIOS and OsteoPerio Study visits.
Data collection
Plasma vitamin D. Fasting venous blood samples were obtained at OsteoPerio Study baseline and follow-up. Plasma samples were stored in liquid nitrogen at 2196°C until the time of 25(OH)D assessment [as previously described (14) ]. Samples were then removed from liquid nitrogen, put in a 280°C freezer, thawed, and divided into aliquots under standard protocol and placed in cryovials. Refrozen samples were shipped to the Heartland Assays, Inc., laboratory over a consecutive 4-mo period. Samples were assessed by competitive chemiluminescence immunoassay by using the DiaSorin LIAISON 25(OH)D assay. Although duplicate participant samples were analyzed in separate batches, the within-pair CV, determined by using the investigatorÕs blinded control samples nested in each batch, was 4.9%. Baseline samples for participants were analyzed first followed by samples collected at followup [as previously described (14) ]. 25(OH)D concentrations (nmol/L) were defined using the following categories: deficiency (<30), inadequacy (30 to <50), and adequacy (2 categories: 50 to < 75 and $75) (17).
Physical measures. Height (m) was measured with a stadiometer and weight (kg) with a calibrated balance beam; from these measures BMI (kg/m 2 ) was calculated. DXA (Hologic QDR-4500A) was used to measure the percentage of fat mass of the trunk and total body. DXA was also used to measure hip and whole-body bone densities from which T scores were derived. T scores represent the number of SD below the mean bone density for healthy young adults, and lower T scores are indicative of lower bone density (24) . Each of these physical measures was assessed at OsteoPerio Study baseline and follow-up clinic visits according to standard protocols.
Estimates of sunlight exposure. At the WHIOS y 4 assessment (1997-2002; 1 y after baseline OsteoPerio Study enrollment), selfreported information regarding sunlight exposure was ascertained. Time spent outside (categorized as <30 min, 30 min to 2 h, and >2 h/d) during the summer and during other months (fall/winter/spring) for the past year was ascertained. Because these questions were asked only at WHIOS y 4, we also examined season of blood draw and physical activity, both assessed at OsteoPerio Study baseline and follow-up, also as proxy measures of sunlight exposure.
The season of blood draw was dichotomized into summer/fall (JuneNovember) and winter/spring (December-May). On the basis of previous studies (25, 26) , duration (min/wk) of recreational physical activity (sum of walking and mild, moderate, and strenuous exercise durations), as opposed to intensity, was chosen as a potential predictive variable. The duration of time spent outside in the sun while being physically active is thought to explain the frequently observed association between physical activity and 25(OH)D concentrations and thus is a reasonable proxy measure for individual sunlight exposure.
Other potential predictors. At baseline, age (y), race (white/nonwhite), and education (high school or less, some education after high school, college degree or higher) were self-reported. Data for the following were collected at both OsteoPerio Study baseline and follow-up: vitamin D intake from foods and supplements (mg/d), alcohol intake (grams consumed in the past year), smoking status (never, past, or current), and current medication use (yes or no). Vitamin D intake in mg/d (1 mg = 40 IU) from foods was assessed with a validated FFQ that was specifically designed for the WomenÕs Health Initiative and described elsewhere (27) . In addition, at OsteoPerio Study baseline and follow-up participants brought in any medications or supplements they were taking, and study personnel recorded the name, frequency of use, and dose. Both amount of vitamin D supplements (mg/d) taken and current use of medications (yes or no) were extracted from these data. On the basis of previous studies (2, 5) , use of medications that could affect vitamin D status were examined, including hormone therapy, oral corticosteroids, and anticoagulant, anticonvulsant, antihypertensive, and osteoporosis-related medications (alendronate, miacalcin, raloxifene, and risedronate).
Statistical analysis
Among the 934 women with baseline plasma 25(OH)D samples, we compared baseline characteristics of those who were included (n = 668) and excluded (n = 266), as described above, from our analytic sample. Comparisons were made between age, education, and baseline measures of plasma 25(OH)D and intake of vitamin D, BMI, and duration of recreational physical activity. In addition, descriptive statistics were computed for baseline and follow-up measures of plasma 25(OH)D concentrations and potential predictors among the 668 women included in our analytic sample. Continuous variables (mean 6 SD) were compared with paired t tests, and McNemarÕs tests were used to compare frequencies of categorical variables.
Change in 25(OH)D was calculated by subtracting baseline from the 5-y follow-up 25(OH)D concentrations. Also determined were changes in the following potential predictor measures over 5 y (follow-up minus baseline): vitamin D intake from foods and supplements, duration of recreational physical activity, BMI, percentage of fat mass of the trunk and total body, hip and whole-body T scores, alcohol intake, smoking status, and medication use. For 25(OH)D and continuous predictors, negative change values indicate a decrease and positive change values indicate an increase in that variable from baseline to follow-up. For categorical predictors (smoking status and medication use), negative change values indicate that the behavior was present at baseline but ceased by follow-up, and positive change values indicate that the behavior was not present at baseline but commenced by follow-up. In addition, change in season of blood draw was examined as a predictor and was categorized as follows: 1) no change in season from baseline to follow-up, 2) blood draw during summer/fall at baseline and winter/ spring at follow-up, and 3) blood draw during winter/spring at baseline and summer/fall at follow-up.
Simple linear regression was used to examine the crude associations between each potential predictor and change in 25(OH)D. To avoid multicollinearity between anthropometric measures, only BMI (baseline R 2 = 0.001; change R 2 = 0.015) was considered for inclusion in the multivariable model because BMI explained more of the variance (i.e., had the largest R 2 ) in 25(OH)D change than did baseline waist circumference (R 2 = 0.002) and percentage of fat mass of both the trunk (baseline R 2 = 0.005; change R 2 = 0.003) and total body (baseline and change R 2 = 0.003) in univariate analyses. Similarly, only vitamin D supplement intake (baseline R 2 = 0.017; change R 2 = 0.062) was considered for inclusion in the multivariable model because it explained more of the variance in change in 25(OH)D univariately than did vitamin D intake from foods (baseline and change R 2 = 0.001) or total vitamin D intake from foods and supplements (baseline R 2 = 0.012; change R 2 = 0.044). Also, whole-body T score (baseline and change R 2 = 0.005) was included in the multivariable model because it explained more of the variance in change in 25(OH)D univariately than did hip T score (baseline and change R 2 = 0.001). Next, stepwise linear regression was used to build the most predictive multivariable model for change in 25(OH)D. The entry criterion for predictors was P < 0.10, and the removal criterion was P > 0.05. The following variables were entered into the stepwise regression model: baseline 25(OH)D; baseline age, race, and education, time spent in the sun during summer and during fall/winter/spring at WHIOS y 4; both baseline and the change in vitamin D supplement intake, duration of recreational physical activity, BMI, whole-body T score, alcohol intake, smoking status, medication use (hormone therapy, cortical steroids, and anticoagulant, anticonvulsant, antihypertensive, and osteoporosis-related medications); and change in season of blood draw. The stepwise regression model was built in a sample size of n = 594. Any of the 668 participants who were missing potential predictor variables were dropped from the stepwise analysis (see Table 1 for noted missing data). The predictive variables identified from the stepwise regression were included in a multivariable model to determine the b-coefficients, respective P values, and R 2 for the overall predictive model. All statistical analyses were performed with SAS version 9.2 (29) . All tests were 2-sided, and P < 0.05 was considered significant.
Results
Women with baseline 25(OH)D samples who were included (n = 668) compared with those who were excluded (n = 266) from our analytical sample were younger (mean age: 65.7 vs. 68.9 y; P < 0.0001) and had slightly lower mean intake of vitamin D from foods (5.0 vs. 5.5 mg/d, P < 0.04). There were no significant differences between women with respect to educational level and baseline measures of plasma 25(OH)D, vitamin D intake from supplements or food and supplements combined, BMI, or time spent in recreational physical activity (see Supplemental  Table 1 ).
Most women were white (98.7%) and most had at least a college degree (48.2%). The mean age of participants was 65.7 y at baseline and 70.2 y at follow-up. Mean 25(OH)D increased from 59.9 nmol/L (range: 5.9-147 nmol/L) at baseline to 67.6 nmol/L (range: 13.0-145 nmol/L) at follow-up (P < 0.001) ( Table 1) . Furthermore, more women had adequate 25(OH)D ($50 nmol/L) at follow-up (80.5%) compared with baseline (67.8%; P < 0.001). Over the 5-y follow-up period, vitamin D intake from foods and supplements, alcohol intake, and medication use (anticoagulant, anticonvulsant, antihypertensive, and osteoporosis-related medications) increased. Alternatively, womenÕs percentage of fat mass of the trunk, hip, and wholebody T scores, and hormone therapy use decreased. At baseline, 72% of women reported using vitamin D supplements and 89% reported use at follow-up (data not shown).
The final variables included in the predictive model are noted in Table 2 . The final predictive model included a sample size of 643 because 25 subjects were missing data on the selected predictors. Both change in whole-body T score and baseline current hormone therapy use were included in the predictive model, although their associated P values for the multivariate model were >0.05. In the stepwise regression analysis, which was performed in a sample size of 594 women, these variables were selected on the basis of the previously noted inclusion and exclusion criteria. In the final predictive model, with a larger sample size of 643, they were no longer significant. We have included them in our multivariate model to be conservative.
In univariate analyses, increasing intake in vitamin D supplements, increasing duration of recreational physical activity, and increasing whole-body T score over time were positively associated with increasing 25(OH)D concentrations ( Table 2) 4 Assessed at the WomenÕs Health Initiative Observational Study 4-y follow-up. 5 Recreational physical activity included walking and mild, moderate, and strenuous exercise. 6 Waist circumference was measured only at the baseline clinic visit. 7 Osteoporosis-related medications included alendronate, miacalcin, raloxifene, and risedronate. In addition, change in time spent engaged in recreational physical activity and change in season of blood draw, both proxy measures of sunlight exposure, also explained a substantial proportion of variance in change in 25(OH)D (3%). This is not surprising because many previous studies have found that sunlight exposure predicts higher 25(OH)D (3) (4) (5) 30) . Although duration of physical activity was examined as a proxy measure of sunlight exposure, it should be noted that location was not ascertained. Thus, the positive association we observed between change in 25(OH)D and change in duration of recreational physical activity may have been attenuated by not being able to exclude indoor activity from our estimate of duration of physical activity.
Changes in BMI and whole-body T score and baseline hormone therapy use together explained an additional 2% of the variance in change in 25(OH)D. Similar to Ding et al. (15), we found an inverse association between changes in BMI and 25(OH)D, independent of other factors (e.g., physical activity). Mason et al. (31) recently conducted a randomized controlled trial that found that weight loss through diet modification and exercise was associated with increases in 25(OH)D. Crosssectional studies have also found greater BMI to be predictive of lower 25(OH)D (2) (3) (4) (5) 7, 8) , and it has been hypothesized that this is the case because vitamin D becomes sequestered in fat tissue (32) . However, change in BMI was a slightly stronger predictor of change in 25(OH)D in this study than was percentage of fat mass of the total body and trunk. Likewise, several previous studies have found BMI, but not percentage of fat mass, to be related to 25(OH)D (33) (34) (35) (36) (37) . The reason for this association is not clear. Perhaps BMI also captures aspects of individual behavior, such as physical activity, sun exposure, and diet, that also predict vitamin D status.
Change in whole-body T score was also a predictor of change in 25(OH)D such that 25(OH)D increased with increasing T score in our sample. Women in the OsteoPerio Study received the results of their DXA scan for bone mineral density. Thus, women with a low whole-body T score at baseline, which is indicative of poor bone health, might have been advised by their doctors to increase their calcium intake (some calcium-rich foods are also fortified with vitamin D), supplementation (calcium supplements often contain vitamin D to increase calcium absorption), and weight-bearing physical activity (if performed outside would increase sun exposure), which could lead to increases in both T score and 25(OH)D. Randomized controlled trials have found that bone density increases after supplementation with vitamin D (38, 39) . Furthermore, it has been suggested that bone density might be a marker for optimal 25(OH)D required to sustain bone health (39) .
Although we found that both hormone therapy users and nonusers increased their 25(OH)D status, baseline hormone therapy users had a greater increase in 25(OH)D. Sowers et al. (40) found that exogenous estrogen use in women was associated with higher 25(OH)D concentrations, which might have been the case because estrogen use has been shown to increase vitamin D-binding protein in the blood (12) which might lead to an increase in 25(OH)D. An alternative explanation is that estrogen and vitamin D compete with each other to bind with megalin, a cellular uptake membrane receptor (41) .
This study has several limitations. Data were collected only twice over 5 y. Many health and lifestyle changes that could have affected 25(OH)D status might have occurred during this timeframe, which might not have been fully captured by the questionnaires. Also, measurement error, such as inaccurate recall, might have led to inaccurate assessment of the predictors. In addition, our sample specifically included white postmenopausal women residing in a northern region of the United States. The participants of the WHIOS are relatively well educated, and it appears that the subset of women included in our current analysis may be slightly younger than other WHIOS women in our broader OsteoPerio Study baseline sample. In our sample, >90% of women reported using vitamin D supplements at follow-up (2002) (2003) (2004) (2005) , which is greater than the 56.3% of women aged >60 y who reported use in the . This suggests that our participants likely engage in health-conscious behaviors, such as supplement use, more so than the general population. Our findings might not be generalizable to males, other age groups, races, or geographic locations, and our results should be interpreted with this limitation in mind.
Despite these potential limitations, our study is, to our knowledge, one of very few prospective studies that have examined predictors of change in 25(OH)D. These data were useful for determining which factors are most responsible for maintaining or increasing 25(OH)D to obtain vitamin D adequacy, as opposed to assessing cross-sectional associations between vitamin D status and predictors. In fact, the prediction of change in 25(OH)D in this study was better than in most cross-sectional studies that explained 19-39% of the variance in a single measure of 25(OH)D (43) (44) (45) (46) (47) (48) (49) . An additional strength of our study was that 25(OH)D measurements were available for the majority of our sample at both study visits (69%) and analyzed by the same lab using the same assay for plasma from both time points, which likely minimizes measurement error.
The WHIOSÕs detailed database allowed us to examine a comprehensive list of potential predictors including demographic, dietary, health-related, and other lifestyle factors. Despite this wealth of data, we were able to explain only 31% of the variation in change in 25(OH)D. There might be other predictors that we did not have measures of or could not account for in our study. Other studies have found that leptin (15) and albumin (16) concentrations explained a substantial proportion of variation in change in 25(OH)D. Race has commonly been shown to be a predictor of 25(OH)D status (3, 5, 7) ; however, our sample was predominantly white. Furthermore, there is some evidence that genetic factors, such as single nucleotide polymorphisms on the vitamin D-binding protein gene, predict 25(OH)D status (9, 50, 51) .
In conclusion, we identified several modifiable and nonmodifiable factors that contributed to the prediction of 5-y change in 25(OH)D, including baseline 25(OH)D, vitamin D supplement intake, duration of physical activity, season of blood draw, BMI, whole-body T score, and hormone therapy use. Increases in blood 25(OH)D associated with change in vitamin D supplementation appear to be influenced by vitamin D status prior to changes in supplementation. Women with low blood 25(OH)D had the greatest response to vitamin D supplementation. Integrating modifiable predictors into oneÕs lifestyle, especially vitamin D supplement intake, could help to maintain or achieve adequate 25(OH)D over time.
